Screener
CRISPR Therapeutics CRSP Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from CRISPR Therapeutics’s reported figures.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
FAQ
- What is CRISPR Therapeutics's invested capital?
- CRISPR Therapeutics (CRSP) reported invested capital of $2.18B in Q1 2026.
- How has CRISPR Therapeutics's invested capital changed year-over-year?
- CRISPR Therapeutics's invested capital increased by 20.2% year-over-year, from $1.81B to $2.18B.
- What is the long-term trend for CRISPR Therapeutics's invested capital?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's invested capital has grown at a 26.2% compound annual growth rate (CAGR), from $557.04M to $1.78B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about CRISPR Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude